Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FluoGuide ASFRA:96X -1.87%39 Buyback Yield % is 0.00 as of Aug. 09, 2026. GuruFocus rates FRA:96X with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 727 Biotechnology companies, FluoGuide AS ranks worse than 137551.44% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for FluoGuide AS's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:96X vs VRTX, REGN, RVMD: Buyback Yield % Comparison
For the Biotechnology subindustry, FluoGuide AS's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FluoGuide AS Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FluoGuide AS's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where FluoGuide AS's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FluoGuide AS (FRA:96X) has a Buyback Yield % of 0.00 as of Aug. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on FluoGuide AS and its competitors. According to the industry distribution chart, FluoGuide AS ranks #999999 out of 727 companies in the Biotechnology industry.
Is FluoGuide AS's Buyback Yield % too high?
FluoGuide AS's current Buyback Yield % is 0.00. Based on the distribution chart, FluoGuide AS ranks #999999 out of 727 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FluoGuide AS has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does FluoGuide AS's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FluoGuide AS ranks #999999 out of 727 companies for Buyback Yield %. This places FluoGuide AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on FluoGuide AS and its competitors. FluoGuide AS's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FluoGuide AS stock overvalued right now?
FluoGuide AS (FRA:96X) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. FluoGuide AS's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For FluoGuide AS (FRA:96X), the current Buyback Yield % is 0.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
39GF Score
Get the complete analysis for FRA:96X
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:96X has been successfully added to your 
